Literature DB >> 24756708

TRPV1.

Stuart Bevan1, Talisia Quallo, David A Andersson.   

Abstract

TRPV1 is a well-characterised channel expressed by a subset of peripheral sensory neurons involved in pain sensation and also at a number of other neuronal and non-neuronal sites in the mammalian body. Functionally, TRPV1 acts as a sensor for noxious heat (greater than ~42 °C). It can also be activated by some endogenous lipid-derived molecules, acidic solutions (pH < 6.5) and some pungent chemicals and food ingredients such as capsaicin, as well as by toxins such as resiniferatoxin and vanillotoxins. Structurally, TRPV1 subunits have six transmembrane (TM) domains with intracellular N- (containing 6 ankyrin-like repeats) and C-termini and a pore region between TM5 and TM6 containing sites that are important for channel activation and ion selectivity. The N- and C- termini have residues and regions that are sites for phosphorylation/dephosphorylation and PI(4,5)P2 binding, which regulate TRPV1 sensitivity and membrane insertion. The channel has several interacting proteins, some of which (e.g. AKAP79/150) are important for TRPV1 phosphorylation. Four TRPV1 subunits form a non-selective, outwardly rectifying ion channel permeable to monovalent and divalent cations with a single-channel conductance of 50-100 pS. TRPV1 channel kinetics reveal multiple open and closed states, and several models for channel activation by voltage, ligand binding and temperature have been proposed. Studies with TRPV1 agonists and antagonists and Trpv1 (-/-) mice have suggested a role for TRPV1 in pain, thermoregulation and osmoregulation, as well as in cough and overactive bladder. TRPV1 antagonists have advanced to clinical trials where findings of drug-induced hyperthermia and loss of heat sensitivity have raised questions about the viability of this therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24756708     DOI: 10.1007/978-3-642-54215-2_9

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  56 in total

Review 1.  Intrathecal Analgesia for Chronic Refractory Pain: Current and Future Prospects.

Authors:  Catherine Smyth; Nadera Ahmadzai; Jason Wentzell; Ashley Pardoe; Andrew Tse; Tiffany Nguyen; Yvette Goddard; Shona Nair; Patricia A Poulin; Becky Skidmore; Mohammed T Ansari
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

2.  Ingestion of transient receptor potential channel agonists attenuates exercise-induced muscle cramps.

Authors:  Daniel H Craighead; Sean W Shank; Jinger S Gottschall; Dennis H Passe; Bob Murray; Lacy M Alexander; W Larry Kenney
Journal:  Muscle Nerve       Date:  2017-05-09       Impact factor: 3.217

Review 3.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 4.  Breaking barriers to novel analgesic drug development.

Authors:  Ajay S Yekkirala; David P Roberson; Bruce P Bean; Clifford J Woolf
Journal:  Nat Rev Drug Discov       Date:  2017-06-09       Impact factor: 84.694

5.  Impaired sweating responses to a passive whole body heat stress in individuals with multiple sclerosis.

Authors:  Dustin R Allen; Mu Huang; Iqra M Parupia; Ariana R Dubelko; Elliot M Frohman; Scott L Davis
Journal:  J Neurophysiol       Date:  2017-03-08       Impact factor: 2.714

Review 6.  Phosphoinositide signaling in somatosensory neurons.

Authors:  Tibor Rohacs
Journal:  Adv Biol Regul       Date:  2015-12-19

Review 7.  Modulation of neuronal excitability by immune mediators in epilepsy.

Authors:  Valentina Iori; Federica Frigerio; Annamaria Vezzani
Journal:  Curr Opin Pharmacol       Date:  2015-11-26       Impact factor: 5.547

Review 8.  Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.

Authors:  Nebojsa Nick Knezevic; Ajay Yekkirala; Tony L Yaksh
Journal:  Anesth Analg       Date:  2017-11       Impact factor: 5.108

9.  Tyrosine Residue in the TRPV1 Vanilloid Binding Pocket Regulates Deactivation Kinetics.

Authors:  Rakesh Kumar; Adina Hazan; Arijit Basu; Nomi Zalcman; Henry Matzner; Avi Priel
Journal:  J Biol Chem       Date:  2016-05-03       Impact factor: 5.157

10.  Novel Radiolabeled Vanilloid with Enhanced Specificity for Human Transient Receptor Potential Vanilloid 1 (TRPV1).

Authors:  Larry V Pearce; Jihyae Ann; Aeran Jung; Shivaji A Thorat; Brienna K A Herold; Amelework D Habtemichael; Peter M Blumberg; Jeewoo Lee
Journal:  J Med Chem       Date:  2017-09-21       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.